Simplex Trading, LLC Genetic Technologies LTD Transaction History

Simplex Trading, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 04, 2023	BUY	$0.8 - $1.13 $355 - $501	444 Added 210.43%	655 $0
Q1 2023 Apr 27, 2023	BUY	$0.86 - $1.82 $181 - $384	211 New	211 $0
Q3 2022 Nov 04, 2022	BUY	$0.0 - $1.57 $0 - $717	457 New	457 $0
Q2 2022 Aug 03, 2022	SELL	$0.0 - $0.01 $0 - $17	-1,784 Closed	0 $0
Q1 2022 May 02, 2022	SELL	$0.0 - $0.0 $0 - $0	-10,042 Reduced 84.91%	1,784 $3,000

Q4 2021 Feb 23, 2022	SELL	$0.0 - $0.01 $0 - $132	-13,270 Reduced 52.88%	11,826 $22,000
Q3 2021 Oct 28, 2021	SELL	$0.0 - $0.01 $0 - $0	-62 Reduced 0.25%	25,096 $107,000
Q2 2021 Aug 12, 2021	SELL	$0.0 - $0.02 $0 - $35	-1,772 Reduced 6.58%	25,158 $106,000
Q1 2021 Apr 26, 2021	BUY	$0.0 - $0.01 $0 - $90	9,065 Added 50.74%	26,930 $112,000
Q4 2020 Feb 02, 2021	BUY	$0.0 - $0.0 $0 - $0	12,580 Added 238.03%	17,865 $64,000
Q3 2020 Oct 14, 2020	BUY	$0.0 - $0.0 $0 - $0	5,285 New	5,285 $18,000

Ticker GENE
Exchange OTC
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 15,389,900
Market Cap $21.5M
Description
Genetic Technologies Limited, a molecular diagnostics company, provides predictive testing and assessment tools to help physicians manage women's health in Australia and the United States. The company's lead product is the BREVAGenplus, a clinically validated risk assessment test for non-hereditary breast cancer. It also markets BREVAGenplus to ...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.